Table 1 Characteristics of PH-COPD patients and RHC and PFT subgroups
Characteristic | All COPD-PH (N = 25,975) | RHC (N = 2325) | PFT (N = 2995) |
|---|---|---|---|
Age, mean (SD) years | 73.5 (9.97) | 70.6 (10.2) | 73.5 (10.1) |
Gendera | |||
Female | 16,573 (63.8%) | 1401 (60.3%) | 2021 (67.5%) |
Male | 9399 (36.2%) | 924 (39.7%) | 974 (32.5%) |
Comorbidities | |||
Hypertension (systemic) | 20,448 (78.7%) | 2050 (88.2%) | 2238 (74.7%) |
Asthma | 16,806 (64.7%) | 1757 (75.6%) | 1792 (59.8%) |
Heart disease | |||
Coronary artery disease | 11,103 (42.7%) | 1593 (68.5%) | 1179 (39.4%) |
Atrial fibrillation | 8184 (31.5%) | 859 (36.9%) | 829 (27.7%) |
Valvular heart disease | 7359 (28.3%) | 1161 (49.9%) | 816 (27.2%) |
Heart failureb | 6974 (26.8%) | 998 (42.9%) | 624 (20.8%) |
Myocardial infarction | 4120 (15.9%) | 486 (20.9%) | 363 (12.1%) |
Diabetes | 8554 (32.9%) | 910 (39.1%) | 968 (32.3%) |
Chronic kidney disease | 7014 (27.0%) | 720 (31.0%) | 760 (25.4%) |
Sleep apnea | 6500 (25.0%) | 831 (35.7%) | 812 (27.1%) |
Stroke | 2137 (8.2%) | 203 (8.7%) | 257 (8.6%) |
Connective tissue disease | 806 (3.1%) | 128 (5.5%) | 136 (4.5%) |